GLENMEDE TRUST CO NA - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 53 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$13,0000.0%3,3000.0%0.00%
Q4 2017$13,000
-18.8%
3,300
-8.3%
0.00%
Q3 2017$16,000
-86.4%
3,600
-72.1%
0.00%
-100.0%
Q2 2017$118,0000.0%12,9000.0%0.00%0.0%
Q1 2017$118,000
-33.0%
12,900
-43.7%
0.00%0.0%
Q4 2016$176,000
-32.6%
22,9000.0%0.00%0.0%
Q3 2016$261,000
-26.1%
22,900
-20.2%
0.00%
-50.0%
Q2 2016$353,000
+21.7%
28,7000.0%0.00%0.0%
Q1 2016$290,000
-55.1%
28,7000.0%0.00%
-50.0%
Q4 2015$646,000
+35.7%
28,7000.0%0.00%
+33.3%
Q3 2015$476,000
-26.2%
28,7000.0%0.00%
-40.0%
Q2 2015$645,000
-12.7%
28,7000.0%0.01%0.0%
Q1 2015$739,000
+18.4%
28,7000.0%0.01%0.0%
Q4 2014$624,000
+14.9%
28,7000.0%0.01%0.0%
Q3 2014$543,000
-18.7%
28,7000.0%0.01%
-16.7%
Q2 2014$668,000
-30.8%
28,7000.0%0.01%
-33.3%
Q1 2014$965,000
+13.9%
28,7000.0%0.01%0.0%
Q4 2013$847,000
+92.9%
28,7000.0%0.01%
+80.0%
Q3 2013$439,00028,7000.01%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
BVF INC/IL 825,647$19,238,0003.04%
SECTORAL ASSET MANAGEMENT INC 1,392,485$32,445,0001.38%
SPHERA FUNDS MANAGEMENT LTD. 75,000$1,748,0000.43%
Eventide Asset Management 52,800$1,230,0000.17%
Alyeska Investment Group, L.P. 250,434$5,835,0000.13%
Convergence Investment Partners, LLC 28,715$669,0000.09%
COLUMBUS CIRCLE INVESTORS 253,348$5,903,0000.04%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 66,800$1,557,0000.04%
Visium Asset Management, LP 75,001$1,748,0000.03%
Hodges Capital Management Inc. 15,000$349,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders